Study found GXDSDP significantly improved anxiety and depression symptoms in CHD patients. Potential alternative treatment option for mental health in cardiovascular disease.
Scientists developed an extraction process for saponins in and plants, showing antioxidant, antihypertensive, hypoglycemic, and anti-inflammatory properties. These saponins could be used in functional foods and natural products.
Study found that ginsenoside Rg1 and PNS from plant relieved depression symptoms in rats. Precise LC-ESI-MS/MS analysis showed positive effects on behavior and hormone levels. Potential antidepressant for humans.
YSGSF boosts bone density by enhancing bone metabolism, but how it treats PMOP is unknown. Study the effects of YSGSF on PMOP to enhance treatment strategies.
Tossers studied CDDP for MI treatment, but focused on endpoints, neglecting dynamic changes in disease. Establishing dynamic research strategy for precise clinical medication guidance is crucial.
Improved IF-MALDI-MS method used to study binding of Panax notoginseng saponins with lysozyme. Results show binding affinity order and suggest hydrogen bonding role. Valuable for screening natural products for pharmacological activities.
Notoginseng leaf triterpenes enhance angiogenesis after stroke by activating Nrf2 and AMPK/SIRT1 pathways, promoting neuroprotection and neuronal regeneration. Potential future stroke treatment.
Researchers studied how to increase levels of minor saponins in Panax notoginseng, which have stronger medicinal effects than major saponins. This information is important for improving treatments for cardiovascular diseases.
Porcine epidemic diarrhea virus (PEDV) causes deadly diarrhea in piglets, impacting the swine industry. Panax notoginseng saponins (PNS) inhibit PEDV replication in cells, potentially offering antiviral therapy options.
Ginsenoside Rb1 can mitigate aconitine-induced cardiotoxicity by reducing myocardial damage and restoring action potential and calcium signaling balance. This study shows potential for using Rb1 as a detoxifying agent in traditional Chinese medicine.
NGR1 from Panax notoginseng repairs damaged intestinal barrier in colitis mice by promoting Lgr5 stem cells through Wnt signaling pathway, reducing inflammation and enhancing epithelial repair. Potential therapeutic for IBD.
RN0D from Panax notoginseng induces mitochondrial dysfunction in cancer cells, leading to cell death through ATP deprivation and mitophagy. Targets Galectin-3 and activates PINK1/Parkin pathway, showing promise as an anticancer therapeutic.
Notoginsenoside Fc (Fc) from Panax Notoginseng may protect against diabetic nephropathy, offering potential therapy for end-stage renal disease in diabetes.
PNS from Panax notoginseng can treat COPD with HCS by reducing blood clotting. Important for managing risk factors in COPD patients.